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Oxidative stress in hemodialysis patients: Is NADPH oxidase prevent further tissue injury in HD patients will be dis-
complex the culprit? cussed.
Oxidative stress results from an imbalance between oxidant
production, including reactive oxygen species (ROS), reactive
nitrogen species (RNS), chlorinated compounds, and antioxi- OXIDATIVE STRESS: A COMMON FEATURE
dant defense mechanisms. Most reports prove that oxidative
OF HD PATIENTS OR A MARKER OFstress is present in ESRD patients. Several studies tend to
CO-MORBID CONDITION?accreditate the hypothesis by which oxidative stress is a strong
co-factor for the development of complications related to long- The imbalance between antioxidant defense mecha-
term HD such as atherosclerosis, amyloidosis, malnutrition, nisms and overproduction of oxidants including reactiveanemia, and infection.
oxygen species (ROS), reactive nitrogen species (RNS),In order to evaluate the rationale for curative action against
and chlorinated compounds is now well established inoxidative damage in chronic renal failure patients, we reviewed
the putative factors involved in this process. Antioxidant sys- HD patients [1, 2]. Several markers of oxidative stress
tems are severely impaired in uremic patients and gradually concerning lipid, protein, carbohydrate, and nucleotide
altered with the degree of renal failure. Moreover, the inflam-
metabolism have been identified. Lipid peroxidationmatory state caused by the hemoincompatibility of the dialysis
products, namely malonyldialdehyde (MDA), 4-hydro-system plays a critical role in the activation of NADPH oxidase,
aggravating the pro-oxidant status of uremic patients. xynonenal (HNE) and F2-isoprostanes, enzymatically
Prevention of ROS overproduction by improvement of dial- produced by free radical-catalyzed peroxidation of ara-
ysis biocompatibility, an important component of adequate chidonoyl lipids, have been consistently reported ele-
dialysis, might be completed by antioxidant supplementation.
vated in HD patients [3, 4]. Advanced glycation products
(AGEs) formed from proteins and peptides by non-enzy-
matic glycation and/or glycoxidation have been identi-
To date, oxidative stress, which occurs when there
fied as a marker of oxidative stress in the anemic popula-
is excessive oxidant production and/or low antioxidant
tion [5]. More recently, Witko-Sarsat et al identified in
levels, has emerged as a strong pathogenesis co-factor
uremic patients the presence of oxidatively modified pro-
implicated in the development of long-term complica-
teins, referred to as advanced oxidation protein products
tions such as atherosclerosis, amyloidosis, malnutrition,
(AOPPs) [6], recognized as novel markers of oxidativeanemia, and infection observed in long-term HD pa-
stress and, more interestingly, as potent mediators oftients. There is an increasing body of evidence attesting
inflammation [7]. To date, 8 hydroxy 2’-deoxyguanosineto the multifactorial origin of oxidative stress. Uremia
(8-OH dG) resulting from leukocyte DNA damage hasper se is largely incriminated in its genesis but renal
been identified as a surrogate marker of oxidative stressreplacement therapy contributes to a large extent to ex-
in the HD population [8]. Taken together, these findingsacerbating and perpetuating this phenomenon.
lead to the conclusion that oxidative stress is presentThis article updates our knowledge of oxidative stress
and may play a major role in CRF and in HD patients.in chronic renal failure (CRF) and HD patients. Thera-
Recognizing the pathogenic role of oxidative stress,peutic alternatives to restore the oxidative balance and
can one speculate that the degree of oxidative stress is
the same for all HD patients? In other words, to what
extent is oxidative stress a constant feature of HD pa-Key words: oxidative stress, hemodialysis, malnutrition, inflammation,
atherosclerosis, NADPH oxidase. tients? To elucidate that aspect, we evaluated in a cross-
sectionnal study oxidative stress in two cohorts of HD 2002 by the International Society of Nephrology
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patients: home HD and center HD. MDA, AOPP, eryth- p21rac) with the membrane-associated flavocytochrome,
cytochrome b558 (Fig. 1). This translocation is dependentrocyte glutathione (erGSH), erythrocyte (er), and plas-
ma (pl) vitamin E (vit E) levels were determined in on the co-operative action of the various components
involving multiple p47phox-directed phosphorylationthe predialysis sera. Results clearly indicated significant
differences in center versus home HD patients (MDA: events [18]. The activated NADPH oxidase complex cat-
alyzes the reduction of molecular oxygen O2 into super-1.83  0.08 vs. 1.60  0.10 mmol/L; AOPP: 90.9  4.4
vs. 66.9  2.9 mol/L; er GSH: 6.5  0.3 vs. 5.0  0.7 oxide anion O-2 that then rapidly dismutates to form
hydrogen peroxide H2O2, a reaction catalyzed by super-mmol/mg Hb; er vit E: 0.94  0.07 vs. 0.40  0.06 mg/L
pellet, and pl vit E: 17.0  1.0 vs. 13.0  1.1 mg/L). Such oxide dismutase (SOD). Thereafter, under the action
of MPO, an enzyme present in azurophilic granules oforiginal findings could in part explain the differences
reported in the literature regarding the ex vivo LDL leukocytes, H2O2 interacts with halides to produce hypo-
chlorous acids; the latter could generate long-lived oxi-oxidizability, being normal by some studies [9] or in-
creased by others [10, 11] when HD patients were com- dants such as chloramines. Such reactions triggered by
the NADPH oxidase, beneficial for bacterial killing, rep-pared with normal subjects. At this stage, one must re-
gard that oxidative stress is not uniformly distributed resents a deleterious source of ROS production in CRF.
The mechanisms implied are therefore unidentified, butin the HD population. Moreover, we hypothesized that
oxidative stress is a marker of co-morbid state in ESRD uremic toxins are suspected to be “provocateurs.”
Hemoincompatibility of the dialysis system resultingpatients as well as malnutrition, inflammation, or athero-
sclerosis [12]. Stenvinkel et al first established a link in chronic inflammation may also play a critical role in
neutrophil priming resulting in overproduction of oxi-between nutritional, inflammatory markers and cardio-
vascular diseases, which they described as “MIA syn- dants. HD-related oxidative stress relies on two major
components of the dialysis system: One is the dialyzerdrome” [13]. Interestingly, the author found significant
differences in terms of inflammation, atherosclerosis, and membrane [19], the other the microbial contamination
and/or the pyrogen content of the dialysate. Contributionoxidative stress according to the nutritional state of pa-
of the bioimcompatible dialyzer membrane to the pro-tients. Malnourished patients had significantly increased
duction of free oxygen radicals has been shown in acuteintima-media thickness, elevated CRP and fibrinogen
HD conditions by comparing cellulosic (cuprophane) tolevels, and lower plasma vitamin E levels compared with
synthetic (polysulfone) membranes [20, 21]. More re-well-nourished patients.
cently, Chen et al have shown that basal blood levels ofWith respect to these results, it can be concluded that
superoxide anion were higher in chronic HD patientspresence of pro-oxidant state is not a constant pattern
compared with healthy subjects and further increased byof HD patients but is strongly linked to the co-morbid
HD sessions [16]. Indirect evidences also exist suggestingconditions of patients.
that trace amounts of endotoxin (LPS) in dialysate are
potent triggers of ROS production via the activation of
OXIDATIVE STRESS IN HD PATIENTS: A PMNs. DeLeo et al showed that neutrophils harvested
COMPONENT OF THE MICROINFLAMMATION from normal human volunteers exposed to bacterial LPS
STATE RELATED TO BIOINCOMPATIBILITY? up-regulated NADPH oxidase assembly [22]. We also
Overproduction of oxidants in HD patients is facili- showed that LPS was able to prime respiratory burst of
tated by the uremic state. Uremia-associated metabolic phagocytes using two in vitro models, THP-1-derived
abnormalities are triggered by the bioincompatibility of monocytes and whole blood. LPS pretreatment strongly
the dialysis procedure. increased O-2 production in THP-1-derived monocytes
It is now well documented that uremia-associated met- (24-h incubation) and whole blood in response to phor-
abolic abnormalities include complex alterations of ROS bol myristate acetate activation (activation percentage:
production [14]. Indeed, Ward et al clearly showed that 210  46% and 212  22%, respectively; P  0.05)
polymorphonuclear cells (PMNs) are in a “primed” state (Fig. 2). These results suggest that endotoxins and frag-
in patients with CRF [15, 16]. PMN “priming” refers in ments of LPS act as priming mediators capable of ampli-
this case to a process whereby the response of PMNs to fying the oxidant production by monocytes. One can
a stimulus is amplified by prior exposure to a priming conclude that endotoxin-contaminated dialysate syner-
agent [17]. Among functional consequences of neutro- gistically amplify ROS production and cytokine-inducing
phil priming, enhancement of the respiratory burst re- ability by activating phagocytes [23, 24]. To date, it has
sulting in a ROS production is being considered as an been shown that the presence of LPS in the dialysate
appropriate response. Full activation of the respiratory may activate blood monocyte/macrophage through the
burst activity in the neutrophil results from translocation dialyzer membrane contributing to IL-1, IL-6 and TNF-
and assembly of the cytosolic components of the induction [25, 26] and the up-regulation of NADPH oxi-
dase complex [27, 28]. In addition to this cytokine effectNADPH oxidase enzyme system (p47phox, p67phox, and
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Fig. 1. “Respiratory burst” of phagocytes. Regulation of NADPH oxidase enzymatic complex. Translocation and assembly of the cytosolic
components of the NADPH oxidase enzyme system (p47phox, p67phox, p21rac) with the membrane-associated flavocytochrome, cytochrome, and further
multiple p47phox phosphorylation events lead to activated NADPH oxidase which in turn catalyzes the reduction of molecular oxygen O2 into O-2 .
Fig. 2. Effect of LPS (A) and vitamin E (B) on superoxide production by THP-1-derived monocytes and whole blood. THP-1-derived monocytes
or whole blood was incubated alternatively with or without LPS (10 ng/mL) for 24 hours and 90 minutes, respectively, and with or without vitamin
E (50 M) for 30 and 60 minutes, respectively. PMA-induced superoxide production was thereafter measured by chemiluminescence analysis.
Values were considered statistically significant at P  0.05 (*). Vehicle (); LPS (); vitamin E ( ).
on ROS production, it is important to note that ROS matory cytokines associated with excessive deleterious
ROS production, underlies an amplification loop throughmodulates cytokine release via transcription factors in-
cluding NF-B and AP-1 [29]. Endotoxin-contaminated which NADPH oxidase and transcription factors are of
key importance (Fig. 3). Evidence is now provided thatdialysate, by contributing to the release of pro-inflam-
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Fig. 3. Possible pathway of an auto-modulatory process responsible for the microinflammatory state present in HD patients.
NADPH oxidase may play an ambivalent role in the sis prevention. LDL oxidability observed in HD patients
has been reduced significantly after oral vitamine E sup-inflammatory response: as an “effector” (by ROS re-
plementation [34]. More interestingly, a significant re-lease) as well as a “modulator” (in regulating transcrip-
duction in composite cardiovascular disease end pointstion factors) agent of the chronic micro-inflammatory pro-
and myocardial infarction has been reported in thecess now well recognized in HD patients [30].
SPACE study consisting of vitamin E supplementation
in high-risk patients. Such interventions confirm the ben-
THERAPEUTIC INSIGHTS OF OXIDATIVE eficial effect of antioxidants on cardiovascular mortality
STRESS IN HD PATIENTS [35]. Two new therapeutic options based on the extracor-
Prevention and/or reduction of oxidative stress mecha- poreal circuit have recently been introduced.One is vita-
nisms in HD patients should include improving the min E-bound hemodialyzers [36], and the other is hemo-
hemocompatibility of the dialysis system to minimize lipodialysis, which consists of loading HD patients with
oxidant generation during HD sessions and to supple- vitamins E and C via liposomes in the extracorporeal
ment patients with antioxidant compounds to correct circuit [37]. These two dialytic approaches provide a
nutritionnal deficiencies, and to compensate dialytic direct interaction of vitamin E on adherent phagocytes.
losses and consumption from ROS overproduction. Of particular interest, this action appears crucial when
These therapeutic insights aimed at preventing long-term one considers the scavenging effect of vitamin E on oxi-
complications associated with dialysis could be achieved dant release by phagocytes observed during in vitro ex-
with either oral or intravenous supplementation or periments. Indeed, we have evaluated the in vitro effect
through the extraracorporeal circuit. of alpha tocopherol (50 uM) on O-2 production both
Several agents (including selenium) administered in- in THP-1-derived monocytes (30 min incubation) and
travenously have confirmed to be effective and well toler- whole blood (60 min incubation). Interestingly, we ob-
ated clinically [31]. Interestingly, plasma and erythrocyte served that vitamin E had a strong inhibitory effect on
selenium content as well as glutathione peroxidase activ- O-2 production in both models (activation percentage:
ity tended to return toward normal levels [32]. Beneficial 56  1% and 20.5  8.3% in THP-1-derived monocytes
effects of alpha tocopherol (500 mg/day during 6 mo) and whole blood, respectively; P  0.05) (Fig. 2). The
supplementation [33] included (1) oxidative state im- explanation for this phenomenon came afterward, when
alpha tocopherol was shown to inhibit the assembly ofprovement, (2) anemia correction, and (3) atherosclero-
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membrane on the 8-hydroxy 2-deoxyguanosine level in leukocyteNADPH oxidase by preventing the phosphorylation and
DNA of hemodialysis patients. Kidney Int 58:790–799, 2000
the membrane translocation of p47phox [38]. Alternatively, 9. Sutherland W, Walker R, Ball M, et al: Oxidation of low density
lipoproteins from patients with renal failure or renal transplants.anti-cytokine therapies using anti-TNF- antibodies, sol-
Kidney Int 48:227–236, 1995uble TNF- receptors, or IL-1 receptor antagonist are
10. Maggi E, Bellazzi R, Falaschi F, et al: Enhanced LDL oxidation
of particular interest to limit oxidative stress, but pro- in uremic patients: An additional mechanism for accelerated ath-
erosclerosis? Kidney Int 45:876–883, 1994spective studies are needed to investigate the beneficial
11. Morena M, Cristol JP, Dantoine T, et al: Protective effects ofeffect of such therapies on cardiovascular and nutritional
high-density lipoprotein against oxidative stress are impaired in hae-
status in HD patients. modialysis patients. Nephrol Dial Transplant 15:389–395, 2000
12. Stenvinkel P, Heimburger O, Lindholm B, et al: Are there two
types of malnutrition in chronic renal failure? Evidence for rela-
tionships between malnutrition, inflammation and atherosclerosisCONCLUSION
(MIA syndrome). Nephrol Dial Transplant 15:953–960, 2000
Oxidative stress, resulting from an imbalance between 13. Stenvinkel P, Heimburger O, Paultre F, et al: Strong association
between malnutrition, inflammation, and atherosclerosis in chronicpro- and antioxidative mechanisms, is a recognized phe-
renal failure. Kidney Int 55:1899–1911, 1999nomenon in HD patients that contributes to long-term
14. Hasselwander O, Young I: Oxidative stress in chronic renal fail-
complications. The question is still raised of why this ure. Free Radic Res 29:1–11, 1998
15. Ward R, MCLeish K: Polymorphonuclear leukocyte oxidativeprocess is not uniformly distributed in the whole HD
burst is enhanced in patients with chronic renal insufficiency. J Ampopulation. Nevertheless, it is strongly associated to a
Soc Nephrol 5:1697–1702, 1994
degree of co-morbidity as well as malnutrition, inflam- 16. Chen MF, Chang CL, Liou SY: Increase in resting levels of super-
oxide anion in the whole blood of uremic patients on chronicmation, or atherosclerosis. This pro-oxidative state im-
hemodialysis. Blood Purif 16:290–300, 1998plies several factors related to the patient’s condition,
17. Condliffe AM, Hawkins PT, Stephens LR, et al: Priming of
uremia state, and hemodialysis system. When exploring the human neutrophil superoxide generation by tumour necrosis fac-
tor-alpha is signalled by enhanced phosphatidylinositol 3,4,5-tris-mechanisms underlying oxidant overproduction in HD,
phosphate but not inositol 1,4,5-trisphosphate accumulation. FEBSthe NADPH oxidase complex emerges as a key target to
Lett 439:147–151, 1998.
focus on. Thereby, modulation of this enzymatic complex 18. el Benna J, Faust LP, Babior BM: The phosphorylation of
the respiratory burst oxidase component p47phox during neu-appears to be a basic requisite to prevent complications
trophil activation. Phosphorylation of sites recognized by proteinin long-term dialysis patients associated with oxidative kinase C and by proline-directed kinases. J Biol Chem 269:23431–
stress. Inhibition of p47phox phosphorylation by vitamin E 23436, 1994
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primes the neutrophil oxidative burst. Artif Organs 19:801–807, 1995cytokine therapies also emerge as interesting modalities 20. Cristol JP, Canaud B, Rabesandratana H, et al: Enhancement
to reduce ROS overproduction. Finally, it is of interest to of reactive oxygen species production and cell surface markers
expression during hemodialysis. Nephrol Dial Transplant 9:389–speculate on preventive actions by investigating genetic
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the relationship between complement activation and stimulation
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